Premier Veterinary Group PLC Block Listing Application and Directors' Dealings (8202B)
21 June 2016 - 7:47PM
UK Regulatory
TIDMPVG
RNS Number : 8202B
Premier Veterinary Group PLC
21 June 2016
EXERCISE OF OPTIONS AND WARRANTS
DIRECTOR'S DEALING
TOTAL VOTING RIGHTS
BLOCK LISTING APPLICATION
Exercise of options and warrants
London, 21 June 2016: Premier Veterinary Group plc (LSE: PVG)
(the "Company") announces that it has received notices of exercise
of options under the Company's Enterprise Management Incentive
Share Option Plan (the "EMI Plan") from certain employees and a
Director of the Company (the "Option Exercise") to subscribe for a
total of 816,143 new ordinary shares of 10 pence each in the
Company (the "New Ordinary Shares"). The exercise price of the
options is 10.1 pence each.
In addition, the Company has received notice of exercise of
warrants from WG Partners LLP to subscribe for 139,517 New Ordinary
Shares at a price of 10.1 pence per share. Warrants over 279,034
ordinary shares of 10 pence each were granted to WG Partners LLP as
part of the arrangements relating to the reverse acquisition by the
Company of Premier Veterinary Group Limited (now PVG 2007 Limited)
completed in February 2015. The balance of the warrants will vest
and become exercisable with effect from 27 February 2017.
Application has been made to the London Stock Exchange for the
admission of a total of 955,660 New Ordinary Shares to the Official
List of the UK Listing Authority and to trading on the London Stock
Exchange's market for listed securities ("Admission"). Admission is
expected to occur on or around 23 June 2016. The New Ordinary
Shares will rank pari passu with the existing ordinary shares in
the Company.
Directors' dealings
Included in the above total of 816,143 share options are 209,277
options which were exercised by Daniel Smith, a Director of the
Company.
Following the exercise of these options, Daniel Smith owns
209,277 ordinary shares, representing approximately 1.4% of the
Company's enlarged issued share capital. Mr Smith holds no further
share options.
Total voting rights
Following Admission, the Company's enlarged issued share capital
will comprise 14,907,433 ordinary shares. The Company does not hold
any shares in treasury. The figure of 14,907,433 ordinary shares
may be used by shareholders in the Company as the denominator for
the calculations by which they will determine if they are required
to notify their interest in, or a change of interest in, the share
capital of the Company under the FCA's Disclosure and Transparency
Rules.
Block Listing Application
The Company further announces that is has made a block listing
application to the London Stock Exchange for the admission of up to
579,035 ordinary shares of 10 pence each to the Official List of
the UK Listing Authority and to trading on the London Stock
Exchange's market for listed securities.
The block listing application relates to 579,035 shares, being
the total number of shares that could be issued pursuant to the
exercise of all options currently outstanding under the EMI Plan.
If all the options were exercised, the shares that would be issued
would represent approximately 3.88% of the enlarged issued share
capital.
The application for the admission of these shares has been made
in advance for ease of administration as all the outstanding
options under the EMI Plan vested and became exercisable on 27
February 2016.
Shares issued pursuant to the exercise of options under the EMI
Plan will rank pari passu with the existing ordinary shares of 10
pence each in the share capital of the Company.
It is expected that the block admission will become effective on
23 June 2016.
Enquiries:
Premier Veterinary Group plc
Sue Steven, Company Secretary +44 (0)117 370 0300
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDMGZVLMKGVZG
(END) Dow Jones Newswires
June 21, 2016 05:47 ET (09:47 GMT)
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jul 2023 to Jul 2024